A prospective study of outcomes, healthcare resource utilization, and costs associated with postoperative nosocomial infections

Infection Control and Hospital Epidemiology

Volumn 27, Issue 12, 2006, Pages 1291-1298

  Herwaldt, Loreen A ^a,b,c   Cullen, Joseph J ^a   Scholz, David ^b,e   French, Pamela ^e   Zimmerman, M Bridget ^b   Pfaller, Michael A ^a,b   Wenzel, Richard P ^a,c,f   Perl, Trish M ^a,d  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^d JOHNS HOPKINS HOSPITAL   (United States)

^e MBA Town Square Family Foot Care ^*

^f VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT;

ADULT; ARTICLE; COMORBIDITY; DISEASE SEVERITY; DRUG USE; GENERAL SURGERY; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL INFECTION; HOSPITAL READMISSION; HUMAN; INFECTION RATE; INFECTION RISK; KARNOFSKY PERFORMANCE STATUS; LENGTH OF STAY; MAJOR CLINICAL STUDY; MORTALITY; NEUROSURGERY; OUTCOME ASSESSMENT; OUTPATIENT; POSTOPERATIVE INFECTION; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; THORAX SURGERY;

ADULT; AGED; CROSS INFECTION; DELIVERY OF HEALTH CARE; HOSPITAL COSTS; HUMANS; LENGTH OF STAY; MIDDLE AGED; MULTIVARIATE ANALYSIS; POSTOPERATIVE PERIOD; PROSPECTIVE STUDIES; SURGICAL PROCEDURES, OPERATIVE; SURGICAL WOUND INFECTION; TREATMENT OUTCOME;

EID: 33846011877     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/509827     Document Type: Article

References (25)

1. Horan TC, Culver DH, Gaynes RP, et al. Nosocomial infections in surgical patients in the United States, January 1986- June 1992. Infect Control Hosp Epidemiol 1993; 14:73-80.
2. Wenzel RP, Pfaller MA. Feasible and desirable future targets for reducing the costs of hospital infections. J Hosp Infect 1991; 18(Suppl A):94-98.
3. Jarvis WR. Selected aspects of the socioeconomic impact of nosocomial infections: morbidity, mortality, cost and prevention. Infect Control Hosp Epidemiol 1996; 17:552-557.
4. Fridkin SK, Pear SM, Williamson TH, et al. The role of understaffing in central venous catheter-associated bloodstream infection. Infect Control Hosp Epidemiol 1996; 17:150-158.
5. Taylor GJ, Mikell FL, Moses HW, et al. Determinants of hospital charges for coronary artery bypass surgery: the economic consequences of postoperative complications. Am J Cardiol 1990; 65:309-313.
6. Weintraub WS, Jones EL, Craver J, et al. Determinants of prolonged length of stay after coronary bypass surgery. Circulation 1989; 80:276-284.
7. Perl TM, Cullen JJ, Wenzel RP, et al. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. The Mupirocin and the Risk of Staphylococcus aureus Study Team. New Engl J Med 2002; 346: 1871-1877.
8. Herwaldt LA, Swartzendruber SK, Zimmerman MB, et al. Hemorrhage after coronary artery bypass graft procedures. Infect Control Hosp Epidemiol 1998; 19:9-16.
9. Green JW, Wenzel RP. Postoperative wound infections: a controlled study of the increased duration of hospital stay and direct cost of hospitalization. Ann Surg 1977; 185:264-268.
10. Kollef MH, Sharpless L, Vlasnik J, et al. The impact of nosocomial infection on patient outcomes, following cardiac surgery. Chest 1997; 112:666-675.
11. Hollenbeak CS, Murphy DM, Koenig S, et al. The clinical and economic impact of deep chest surgical site infections following coronary artery bypass graft surgery. Chest 2000; 118:397-402.
12. Rebollo MH, Bernal JM, Llorca J, et al. Nosocomial infections in patients having cardiovascular operations: a multivariate analysis of risk factors. J Thorac Cardiovasc Surg 1996; 112:908-913.
13. Kirkland KB, Briggs JP, Trivette SL, et al. The impact of surgical site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol 1999; 20:725-730.
14. Reilly J, Twaddle S, McIntosh J, et al. An economic analysis of surgical wound infection. J Hosp Infect 2001; 49:245-249.
15. Coello R, Glenister H, Fereres J, et al. The cost of infection in surgical patients: a case-control study. J Hosp Infect 1993; 25:239-250.
16. Jenney AW, Harrington GA, Russo PL, et al. Cost of surgical site infections following coronary artery bypass surgery. Aust NZ J Surg 2001; 71: 662-664.
17. Erbaydar S, Akgun A, Eksik A, et al. Estimation of increased hospital stay due to nosocomial infections in surgical patients: comparison of matched groups. J Hosp Infect 1995; 30:149-154.
18. Asensio A, Torres J. Quantifying excess length of postoperative stay attributable to infections: a comparison of methods. J Clin Epidemiol 1999; 52:1249-1256.
19. Merle V, Germain J-M, Chamouni P, et al. Assessment of prolonged hospital stay attributable to surgical site infections using appropriateness evaluation protocol. Am J Infect Control 2000; 28:109-115.
20. Zoutman D, McDonald S, Vethanayangan D. Total and attributable costs of surgical-wound infections at a Canadian tertiary-care center. Infect Control Hosp Epidemiol 1998; 19:254-259.
21. Schulgen G, Kropec A, Kappstein I, et al. Estimation of extra hospital stay attributable to nosocomial infections: heterogeneity and timing of events. J Clin Epidemiol 2000; 53:409-417.
22. Larson L. Cost determination and analysis. In: Bootman IL, Townsend RJ, McGhan WF, eds. Principles of Pharmacoeconomics. 2nd ed. Cincinnati: Harvey Whitney Book Company; 1996:44-59.
23. Finkler SA. The distinction between costs and charges. Ann Intern Med 1982; 96:102-109.
24. Cruse PJE, Foord R. The epidemiology of wound infection: a 10-year prospective study of 62,939 wounds. Surg Clin North Am 1980; 60: 27-40.
25. Wenzel RP. The economics of nosocomial infections. J Hosp Infect 1995; 31:79-87.